Pharm Exec2h
The Teva Turnaround: Steering a Company Comeback
CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...
When blood cancer starts to spread, tumor cells diversify and affect immune response
When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...
New research uncovers hidden rules of immune response, opening doors for better vaccines and immunotherapies
Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline ...
Royalty Pharma Reports Q4 and Full Year 2024 Results
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...
Multiple Sclerosis News Today4h
Smoking, obesity interact to drive faster MS progression, study finds
Researchers suggest the persistent inflammation from obesity may enhance the detrimental effects of intermittent or sustained ...
Frontiers8h
Exploring the Immune-Metabolic Network in Diabetes
Diabetes, as defined by the World Health Organization, represents a collection of metabolic diseases characterized primarily by hyperglycemia, which can ...
Royalty Pharma plc: Royalty Pharma Reports Q4 and Full Year 2024 Results
Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net cash provided by operating activities of $743 million in ...